Open Access. Powered by Scholars. Published by Universities.®

Digital Commons Network

Open Access. Powered by Scholars. Published by Universities.®

Oncology

PDF

DePaul University

Grace Peterson Nursing Research Colloquium

2018

Articles 1 - 2 of 2

Full-Text Articles in Entire DC Network

Needs Assessment For Palliative Care In Pediatric Oncology: An Integrative Literature Review, Tabitha Negrete Nov 2018

Needs Assessment For Palliative Care In Pediatric Oncology: An Integrative Literature Review, Tabitha Negrete

Grace Peterson Nursing Research Colloquium

Abstract

Background: Cancer is the leading cause of non-accidental death in childhood. Cancer is the primary disease for which pediatric palliative care services are utilized worldwide. Improvement in pediatric palliative care has been identified as an ongoing research priority. There are still significant gaps in current knowledge of pediatric palliative care because education has not been integrated into curriculum and clinical experiences.

Objectives: The purpose of this integrative literature review aims to provide a comprehensive review of current research about the need of nursing education on palliative care for long-term care in pediatric oncology.

Methods: This integrative literature review focused …


Systematic Review: Diversity Of Enrollment In Multiple Myeloma Drug Trials Among Different Ethnicities, Kaitlin Adams, Laura Guerrieri Mar 2018

Systematic Review: Diversity Of Enrollment In Multiple Myeloma Drug Trials Among Different Ethnicities, Kaitlin Adams, Laura Guerrieri

Grace Peterson Nursing Research Colloquium

Systematic Review: Diversity of Enrollment in Multiple Myeloma Drug Trials Among Different Ethnicities

Kaitlin Adams & Laura Guerrieri

Faculty Sponsor: Dr. Joseph Tariman

Background & Significance: Multiple Myeloma is 2 to 3 times more prevalent in non-Hispanic Blacks (NHBs) when compared to Non-Hispanic Whites (NHWs), and the overall survival is also dissimilar between these two racial groups. Among patients 65 to 74 years of age, the 10-year Relative Survival Rates (RSRs) have been found to be statistically improved for NHWs (13.3% vs. 20.5%; p =p = .06). Since 2003, The FDA has approved 10 new drugs for myeloma treatment and …